Literature DB >> 22910460

Effect of genetic variant in BICC1 on functional and structural brain changes in depression.

Rachel Bermingham1, Angela Carballedo, Danuta Lisiecka, Andrew Fagan, Derek Morris, Ciara Fahey, Gary Donohoe, James Meaney, Michael Gill, Thomas Frodl.   

Abstract

Genes and early-life adversity (ELA) interactively increase the risk of developing major depressive disorder (MDD). A recent genome-wide association study suggests that the minor T-allele of single-nucleotide polymorphisms in the bicaudal C homolog 1 gene (BICC1) has a protective role against MDD. The aims of the study were to investigate whether the minor T-allele of BICC1 is protective against hippocampal structural brain changes, whether it is associated with increased functional brain activity in the emotion regulation system, and how ELA would modify this association. Forty-four patients with MDD and 44 healthy controls were investigated using structural magnetic resonance imaging (MRI) and functional MRI with an emotion inhibition task. Analysis of a single-nucleotide polymorphism in the BICC1-1 (rs999845) gene was performed. Right hippocampal bodies of patients and controls without a history of ELA and who carry the protective T-allele of BICC1 were significantly larger compared with those participants homozygous for the major C-allele of BICC1. However, MDD patients with ELA, who carry the T-allele, had smaller hippocampal head volumes compared with MDD patients without ELA. FMRI showed that patients and controls carrying the protective T-allele of BICC1 activate the emotion regulation system significantly more compared with those participants homozygous for the major C-allele (p<0.05, family wise error corrected). These results are suggestive that the minor T-allele of BICC1 has a protective role against MDD and its known structural and functional brain changes. However, this protective effect seems to be lost in the case of co-occurrence of ELA.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22910460      PMCID: PMC3499713          DOI: 10.1038/npp.2012.158

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  32 in total

1.  Altered inhibition of negative emotions in subjects at family risk of major depressive disorder.

Authors:  Danuta M Lisiecka; Angela Carballedo; Andrew J Fagan; Gerald Connolly; James Meaney; Thomas Frodl
Journal:  J Psychiatr Res       Date:  2011-11-10       Impact factor: 4.791

2.  Different effects of mirtazapine and venlafaxine on brain activation: an open randomized controlled fMRI study.

Authors:  Thomas Frodl; Johanna Scheuerecker; Veronika Schoepf; Jennifer Linn; Nikolaos Koutsouleris; Arun L W Bokde; Harald Hampel; Hans-Jürgen Möller; Hartmut Brückmann; Martin Wiesmann; Eva Meisenzahl
Journal:  J Clin Psychiatry       Date:  2010-09-21       Impact factor: 4.384

3.  Stress and hippocampal plasticity: implications for the pathophysiology of affective disorders.

Authors:  Bruce S. McEwen; Ana Maria Magarinos
Journal:  Hum Psychopharmacol       Date:  2001-01       Impact factor: 1.672

4.  Standardised assessment and recording of depressive symptoms.

Authors:  M Hamilton
Journal:  Psychiatr Neurol Neurochir       Date:  1969 Mar-Apr

5.  5-HTTLPR biases amygdala activity in response to masked facial expressions in major depression.

Authors:  Udo Dannlowski; Patricia Ohrmann; Jochen Bauer; Jürgen Deckert; Christa Hohoff; Harald Kugel; Volker Arolt; Walter Heindel; Anette Kersting; Bernhard T Baune; Thomas Suslow
Journal:  Neuropsychopharmacology       Date:  2007-04-04       Impact factor: 7.853

6.  Initial reliability and validity of a new retrospective measure of child abuse and neglect.

Authors:  D P Bernstein; L Fink; L Handelsman; J Foote; M Lovejoy; K Wenzel; E Sapareto; J Ruggiero
Journal:  Am J Psychiatry       Date:  1994-08       Impact factor: 18.112

Review 7.  The molecular neurobiology of depression.

Authors:  Vaishnav Krishnan; Eric J Nestler
Journal:  Nature       Date:  2008-10-16       Impact factor: 49.962

8.  The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R).

Authors:  Ronald C Kessler; Patricia Berglund; Olga Demler; Robert Jin; Doreen Koretz; Kathleen R Merikangas; A John Rush; Ellen E Walters; Philip S Wang
Journal:  JAMA       Date:  2003-06-18       Impact factor: 56.272

Review 9.  The HPA axis in major depression: classical theories and new developments.

Authors:  Carmine M Pariante; Stafford L Lightman
Journal:  Trends Neurosci       Date:  2008-07-31       Impact factor: 13.837

10.  Reduced expression of glucocorticoid-inducible genes GILZ and SGK-1: high IL-6 levels are associated with reduced hippocampal volumes in major depressive disorder.

Authors:  T Frodl; A Carballedo; M M Hughes; K Saleh; A Fagan; N Skokauskas; D M McLoughlin; J Meaney; V O'Keane; T J Connor
Journal:  Transl Psychiatry       Date:  2012-03-13       Impact factor: 6.222

View more
  7 in total

Review 1.  Neuroimaging genomic studies in major depressive disorder: A systematic review.

Authors:  Hui-Feng Zhang; David Mellor; Dai-Hui Peng
Journal:  CNS Neurosci Ther       Date:  2018-02-23       Impact factor: 5.243

2.  Single-Nucleotide Polymorphism of the FKBP5 Gene and Childhood Maltreatment as Predictors of Structural Changes in Brain Areas Involved in Emotional Processing in Depression.

Authors:  Leonardo Tozzi; Angela Carballedo; Friedrich Wetterling; Hazel McCarthy; Veronica O'Keane; Michael Gill; Derrek Morris; Ciara Fahey; James Meaney; Thomas Frodl
Journal:  Neuropsychopharmacology       Date:  2015-06-16       Impact factor: 7.853

Review 3.  Protein Translation and Psychiatric Disorders.

Authors:  Sophie Laguesse; Dorit Ron
Journal:  Neuroscientist       Date:  2019-07-04       Impact factor: 7.519

4.  BICC1 expression is elevated in depressed subjects and contributes to depressive behavior in rodents.

Authors:  Kristie T Ota; Wells Andres; David A Lewis; Craig A Stockmeier; Ronald S Duman
Journal:  Neuropsychopharmacology       Date:  2014-09-02       Impact factor: 7.853

Review 5.  Meta-analysis of associations between childhood adversity and hippocampus and amygdala volume in non-clinical and general population samples.

Authors:  Maria Calem; Konstantinos Bromis; Philip McGuire; Craig Morgan; Matthew J Kempton
Journal:  Neuroimage Clin       Date:  2017-02-22       Impact factor: 4.881

Review 6.  Bicaudal-C Post-transcriptional regulator of cell fates and functions.

Authors:  Megan E Dowdle; Charlotte R Kanzler; Cole R K Harder; Samuel Moffet; Maya N Walker; Michael D Sheets
Journal:  Front Cell Dev Biol       Date:  2022-09-07

7.  Analysis of the effects of depression associated polymorphisms on the activity of the BICC1 promoter in amygdala neurones.

Authors:  S Davidson; L Shanley; P Cowie; M Lear; P McGuffin; J P Quinn; P Barrett; A MacKenzie
Journal:  Pharmacogenomics J       Date:  2015-10-06       Impact factor: 3.550

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.